ZAL-36883-53696
3 vaccinations
5 coded responses
34 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-01-09
Registered in v-safe
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-31
-
2021-02-01
Dose 2 — Moderna
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-03-15
Survey response — day 42, dose 2MedDRA: Acne — Feeling: FairFree text: Probably not related, but more problems with acne recently.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-02
-
2021-10-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-29
- 2021-10-30
- 2021-10-31
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness · HeadacheFree text: Tender ipsilateral axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, RednessFree text: Still with tender lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
-
2021-11-14
Survey response — day 14, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Caught a cold, covid test was negativeMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2022-01-28
- 2022-04-29
-
2022-10-29
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-01 | Moderna | |
| 3 | 2021-10-29 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-29 | Unsuccessful |
Free text
Release 5 — day 42, dose 2
Symptoms: Probably not related, but more problems with acne recently.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Tender ipsilateral axillary lymphadenopathy
Systemic reaction (other): Still with tender lymphadenopathy
Release 10 — day 14, dose 3
Symptoms: Caught a cold, covid test was negative
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acne | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release